Summary.-Resistance to the cytocidal action of Adriamycin (ADR) was induced in rat hepatocytes by incorporation of the carcinogen 2-acetylaminofluorene (AAF) into the rat diet. Using a quantitative assay in primary monolayer culture, it was demonstrated that resistance to ADR is an early phenotypic change that is induced during chemical carcinogenesis in the rat, and appears to be stable.
THE CHEMOTHERAPY of disseminated cancer in humans is based on the use of a variety of toxins which are presumed to be more toxic to malignant than to normal cells (Burchenal, 1977) . Cancer chemotherapeutic agents, which are often cytotoxins, act at many levels of cellular control, and have usually been designed to interfere with the action of regulatory macromolecules, including DNA and RNA (Chabner et al., 1977) as well as with several proteins (Abell et al., 1979) . Although these agents are often effective in inhibiting the proliferation of transformed cells in tissue culture or transplantable tumours in animals, they appear to be less useful in the treatment of many of the common epithelial malignancies of adults, as judged by increase in overall patient survival (DHEW Publication, 1976) . Carcinogenaltered, but not normal cells have in general been shown to be resistant to the toxic and antiproliferative effects of many carcinogens (Vasiliev & Guelstein, 1963; Diamond, 1969) . It was therefore reasoned that the clinical resistance of many epithelial malignancies to the antiproliferative action of cytotoxic chemotherapy might be a manifestation of a common phenotypic change in carcinogen-treated epithelial cells, namely, the ability to resist the antiproliferative and cytocidal effects of various toxins.
It has been previously shown that carcinogen-induced hyperplastic liver nodules in the rat were resistant in vivo to the acute effects of toxins which produced necrosis in non-nodular liver and that hepatocytes of carcinogenfed rats were resistant both to the necrogenic effects of aflatoxin B1 in vivo and to the cytocidal effects of aflatoxin B1 in vitro, compared to control rats (Judah et al., 1977) . The resistance of carcinogenaltered rat hepatocytes to the cytocidal effects of various toxins is amenable to quantitative study in vitro (Laishes et al., 1978; Carr, 1980) (Davis et al., 1978) . Like many other antineoplastic agents, it is highly necrogenic (cytocidal) to normal tissues (Ignofo & Friedman, 1980) in addition to its antiproliferative action. It has also been demonstrated to be carcinogenic in the rat (Marquardt et al., 1976 (1978) . Cell suspensions were passed through sterile gauze filters to remove undissociated fragments, and viability was assessed by trypan-blue exclusion. Cells were plated at 106 viable cells per plastic culture flask (Falcon plastics, 25 cm2 surface area) in 4 ml of L-15 medium with Hepes (3.5 mg/inl) and albumin (2 mg/ml) supplemented with 10% foetal bovine serum, penicillin (100 1l/ml) and streptomycin (100 ,ug/ ml). After a 3h attachment period at 37°C in a water-saturated 50/ CO2: 950o air incubator, the cells were washed x 3 in the above medium, and placed in 4 ml of the same medium with or without (controls). ADR was purchased from Adria Laboratories Inc., Columbus, Ohio. Stocks were made in saline at 10 mg/ml, kept at 4°C, and discarded after 3 days.
Quantitation of cell resistance
The monolayer cultures wAere incubated with ADR or without (controls) for 24 h.
Then 0-8 ml of trypan blue was added to the 4 ml of medium in each flask and incubated for 10 min at 37°C. After this, the medium was removed and the number of viable (nonstaining) cells was counted. The percentage of resistant cells was expressed as the number of viable, attached cells in the experimental flasks compared to the number of viable, attached cells in control flasks, which contained the same cells but had no ADR in the medium. Under these experimental conditions, none of the cell types proliferate.
RESULTS
Male F344 rats weighing 150-200 g were fed either a basal diet, or a basal diet containing 0 02% (w/w) 2-acetylaminofluorene (AAF). This agent, when administered in the diet, acts as a mitotic inhibitor of normal rat hepatocytes (Solt et al., 1977) and induces the formation of both hyperplastic nodules and, later, hepatocellular carcinomas (Wilson et al., 1941) . Macroscopic, subeapsular nodules are grossly visible on the livers of rats fed a diet containing 0.02% (w/w) AAF for 12 weeks. Using a quantitative cytotoxicity assay with trypan blue exclusion as the end-point (Laishes et al., 1978) primary monolayer cultures ofhepatocytes from rats fed either basal diet or basal diet plus AAF for 12 weeks were examined for resistance in vitro to the cytotoxic effects of ADR (Fig. 1) . It can be seen that there is a three-log difference in the LD50 for ADR when normal rat hepatocytes (3 x 10-7M ADR) are compared to hepatocytes which are altered by the feeding of AAF (4 x 10-4M ADR). The figures represent the averages ( ± s.d.) for 3 normal and 3 carcinogen-fed rats. For each animal, 3 flasks were counted for each drug concentration, and the average number of cells in 15 fields of view was computed. Control flasks demonstrated that attachment efficiencies were similar for both normal and carcinogenaltered hepatocytes, and ranged from 65 to 80%. Selective detachment did not occur either, since no more than 15%0 of floating cells were found in control flasks for either cell type at 24 h.
The duration of carcinogen feeding needed for production of the resistant hepatocyte phenotype was determined. Rats were placed on the AAF diet and killed at intervals after the start of car- cinogen feeding. The hepatocytes were then harvested and placed in primary monolayer culture, and the percentage of surviving cells in the presence of ADR 1 8 x 10-4M was measured, compared to the control flasks without ADR (as described above). Fig. 2a represents the results of 3 experiments, and shows that the carcinogen-induced resistance to the cytocidal action of ADR, as measured in vitro, had appeared after 24 h of carcinogen feeding (Fig. 2a) . Furthermore, most of the increase in resistance occurred by 1 week of continuous feeding of carcinogen, and did not decrease with time.
In order to estimate the stability of the carcinogen-induced, resistant phenotype, rats were fed an AAF-containing diet and then killed after return to a basal, non-carcinogenic diet. Fig. 2b illustrates the pattern of resistance after 4 weeks of continuous carcinogen administration in the diet, and a subsequent return to a carcinogen-free diet. Each point represents the average (± s.d.) for 3 rats. It can be seen that for a further 2 months there is little loss of resistance to the cytocidal effects of ADR, as measured in rat hepatocytes in vitro.
DISC t SS1ON
The toxicity of many carcinogens led Haddow (1938) to suggest that in response to carcinogen-induced inhibition of normal cell proliferation a new cell type is formed which may grow even in the presence of toxic carcinogens. The differential resistance of carcinogen-altered cells to toxicity by carcinogens was the basis of a clonalselection theory of cancer (Prehn, 1964) and experimental support for these ideas has recently included the ability of carcinogen-altered cells to proliferate selectively in vivo in a carcinogen-induced, toxic environment (Solt & Farber, 1976) . The experiments reported here show that hepatocytes from AAF-treated rats are resistant to the cytocidal effects of the anthracyclene antibiotic ADR at concentrations which are toxic to hepatocytes from normal rats. Resistance occurs very early in hepatocarcinogenesis, even before new cell populations have developed (Laws et al., 1952; Farber, 1956) . However, the stability of the ADR resistant phenotype observed in the present study could be attributed, at least in part, to new cell populations that have developed in this time (Laws et al., 1952; Farber, 1956 ). The significance of these observations is not yet clear. A high proportion of the cell population exhibits the resistant phenotype, and presumably not all of these cells participate in the carcinogenic process. However, presumptive preneoplastic cells, staining positively for the marker y-glutamyltranspeptidase, comprise about 44%0 of hepatocytes after 14 weeks of feeding a diet containing AAF, which is several months before the appearance of cancer. In addition, there are many more hyperplastic nodules than subsequent cancers. Whether these represent different subpopulations of carcinogen-altered cells remains to be determined. The proportion of cells in a given organ which are capable of developing into cancer during chronic carcinogen administration is also unknown. However, the relatively short lifespan of rodents and the death from the effects of one or few foci of cancer lead to difficulties in devising experiments on these issues.
If these observations reflect some of the changes that occur in the early development of human hepatocellular carcinoma (HCC), then HCC cells would appear to be particularly adept at resisting the cytocidal effects of a variety of cytotoxins, including Adriamycin. Current experiments are focusing on the mechanisms likely to be responsible for the carcinogeninduced resistance. These include a carcinogen-induced alteration in the membrane transport for ADR; a decrease in the microsome-mediated activation of ADR to its superoxide forms; an increased catabolism to inactive ADR metabolites; or the induction by the carcinogen of cellular mechanisms for abrogating the toxic effects of active radicals of ADR, which might include glutathione, catalase, peroxidases and superoxide dismutase.
